ストックスクリーナーアプリを入手
3.82
4.50%
-0.18
アフターアワーズ：
3.98
0.16
+4.19%
前日終値:
$4.00
開ける：
$3.95
24時間の取引高:
177.37K
Relative Volume:
0.44
時価総額：
$27.70M
収益：
-
当期純損益:
$-29.01M
株価収益率:
-0.079
EPS:
-48.3535
ネットキャッシュフロー:
$-29.34M
1週間 パフォーマンス:
-2.55%
1か月 パフォーマンス:
-21.88%
6か月 パフォーマンス:
-49.74%
1年 パフォーマンス:
+0.53%
1日の値動き範囲:
$3.74
$3.95
1週間の範囲:
$3.60
$4.03
52週間の値動き範囲:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
名前
Briacell Therapeutics Corp
セクター
電話
(604) 921-1810
住所
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.82 | 29.00M | 0 | -29.01M | -29.34M | -48.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-02-14 | 開始されました | H.C. Wainwright | Buy |
Briacell Therapeutics Corp (BCTX) 最新ニュース
Street Watch: Is BriaCell Therapeutics Corp a defensive stock2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - National Today
BriaCell Restructures Soluble CD80 Program via BriaPro Deal - TipRanks
BriaCell enters asset sale to BriaPro for sCD80, receives 23.97M shares and up to $3M credit - TradingView
(BCT) Investment Performance Report (BCT:CA) - Stock Traders Daily
Is BriaCell Therapeutics Corp. stock a top pick in earnings seasonJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - mfd.ru
Bull Run: What is BriaCell Therapeutics Corp. Equity Warrant’s valuation compared to sector2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - Intellectia AI
BriaCell (BCTX) Expands Biologic Cancer Treatments Through New A - GuruFocus
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal - TipRanks
BriaCell Therapeutics Brief: BriaCell and BriaPro Entering Into Asset Purchase Agreement for Exclusive Soluble CD80 License - marketscreener.com
Will BriaCell Therapeutics Corp. Equity Warrant stock maintain momentum in 2025Market Activity Report & Verified Chart Pattern Signals - mfd.ru
BriaCell Therapeutics Corp. Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer - marketscreener.com
(BCT) Technical Patterns and Signals (BCT:CA) - Stock Traders Daily
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial - TipRanks
BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue - marketscreener.com
Data Safety Review Board Issues Positive Safety Recommendation For BriaCell's Phase 3 Study - marketscreener.com
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - The Manila Times
BriaCell Receives Positive Recommendation from Data Safety - GlobeNewswire
BriaCell Awarded New Zealand Patent for its Whole Cell Technology - Intellectia AI
Why BriaCell Therapeutics Corp. stock could be next big winnerTrade Exit Summary & High Conviction Buy Zone Alerts - mfd.ru
What is BriaCell Therapeutics Corp. Equity Warrant s debt to equity ratioJuly 2025 Spike Watch & Consistent Return Investment Signals - mfd.ru
Entry Recap: Will BriaCell Therapeutics Corp. stock go up in YEARTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru
Is now the right time to enter BriaCell Therapeutics Corp.2025 Fundamental Recap & Risk Controlled Daily Plans - mfd.ru
Will BriaCell Therapeutics Corp. Equity Warrant announce a stock splitJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru
Can BriaCell Therapeutics Corp. stock maintain growth trajectoryPrice Action & Free Low Drawdown Momentum Trade Ideas - mfd.ru
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
Published on: 2026-02-14 21:45:18 - mfd.ru
Does BriaCell Therapeutics Corp. Equity Warrant have pricing powerMarket Activity Report & Technical Confirmation Alerts - mfd.ru
Will BriaCell Therapeutics Corp. Equity Warrant stock outperform value stocks2025 Winners & Losers & Community Verified Swing Trade Signals - mfd.ru
Does BriaCell Therapeutics Corp. stock have upside surprise potentialJuly 2025 Momentum & Consistent Return Strategy Ideas - mfd.ru
Is now the right time to enter BriaCell Therapeutics Corp. Equity Warrant2025 Volume Leaders & Safe Capital Growth Tips - mfd.ru
When (BCT) Moves Investors should Listen (BCT:CA) - Stock Traders Daily
(BCT) Long Term Investment Analysis (BCT:CA) - Stock Traders Daily
Published on: 2026-02-07 21:02:33 - baoquankhu1.vn
Published on: 2026-02-07 19:20:19 - baoquankhu1.vn
Market Recap: Does BriaCell Therapeutics Corp align with a passive investing strategyWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn
Published on: 2026-02-06 19:26:35 - baoquankhu1.vn
Published on: 2026-02-04 18:01:12 - baoquankhu1.vn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
Big Picture: Should I buy BriaCell Therapeutics Corp Equity Warrant stock nowEarnings Recap Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
How does BriaCell Therapeutics Corp. Equity Warrant compare to its peersJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Will BriaCell Therapeutics Corp. stock hit new highs in YEAR2025 Risk Factors & AI Powered Trade Plan Recommendations - mfd.ru
What’s the profit margin of BriaCell Therapeutics Corp. Equity WarrantPortfolio Gains Summary & Weekly Top Stock Performers List - mfd.ru
BriaCell Brief: Says Patients' Images Show Regression And Resolution Of Metastasized Tumors And Immune Activation - marketscreener.com
(BCT) Equity Market Report (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment - GuruFocus
BriaCell Treatment Shows Significant Efficacy in Cancer Patients - Intellectia AI
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation - Sahm
Can BriaCell Therapeutics Corp. ride the EV waveJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
BriaCell reports long-term survival data in metastatic breast cancer By Investing.com - Investing.com India
Briacell Therapeutics Corp (BCTX) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
0.45%
大文字化:
|
ボリューム (24 時間):